{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:09:17Z","timestamp":1790788157912,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010434","name":"\u201cla Caixa\u201d Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RYC-2013-13054"],"award-info":[{"award-number":["RYC-2013-13054"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR UCLH biomedical research centre","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["752310"],"award-info":[{"award-number":["752310"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-018-0460-1","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T19:06:43Z","timestamp":1548356803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Spatial patterns of white matter hyperintensities associated with Alzheimer\u2019s disease risk factors in a cognitively healthy middle-aged cohort"],"prefix":"10.1186","volume":"11","author":[{"name":"for the ALFA Study","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Salvad\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brugulat-Serrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole H.","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Grau-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Falcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Fauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jorge","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"460_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp.70.1.9","volume":"70","author":"F-E Leeuw De","year":"2001","unstructured":"De Leeuw F-E, de Groot JC, Achten E, Oudkerk M, Ramos L, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70:9\u201314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"460_CR2","doi-asserted-by":"publisher","first-page":"e013215","DOI":"10.1136\/bmjopen-2016-013215","volume":"7","author":"A Brugulat-Serrat","year":"2017","unstructured":"Brugulat-Serrat A, Rojas S, Bargall\u00f3 N, Conesa G, Minguill\u00f3n C, Fauria K, et al. Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer\u2019s disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) project. BMJ Open. 2017;7:e013215.","journal-title":"BMJ Open"},{"key":"460_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157\u201365 Nature Publishing Group.","journal-title":"Nat Rev Neurol"},{"key":"460_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-011-0851-x","volume":"122","author":"R Schmidt","year":"2011","unstructured":"Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol. 2011;122:171\u201385.","journal-title":"Acta Neuropathol"},{"key":"460_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1212\/WNL.0b013e3182a43e45","volume":"81","author":"D Erten-Lyons","year":"2013","unstructured":"Erten-Lyons D, Woltjer R, Kaye J, Mattek N, Dodge HH, Green S, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology. 2013;81:977\u201383.","journal-title":"Neurology"},{"key":"460_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5:735\u201341.","journal-title":"Lancet Neurol"},{"key":"460_CR7","first-page":"835","volume":"67","author":"R Christiane","year":"2010","unstructured":"Christiane R, Ming-Xin T, Schupf N, Manly JJ, Richard M, Luchsinger JA. A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol. 2010;67:835\u201341.","journal-title":"Arch Neurol"},{"key":"460_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiol.2371041496","volume":"237","author":"AD Murray","year":"2005","unstructured":"Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology. 2005;237:251\u20137.","journal-title":"Radiology"},{"key":"460_CR9","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1161\/01.STR.0000135226.53499.85","volume":"35","author":"T Jeerakathil","year":"2004","unstructured":"Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D\u2019Agostino RB, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke. 2004;35:1857\u201361.","journal-title":"Stroke"},{"key":"460_CR10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/brain\/aww008","volume":"139","author":"M Habes","year":"2016","unstructured":"Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, et al. White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain. 2016;139:1164\u201379.","journal-title":"Brain"},{"key":"460_CR11","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1161\/STROKEAHA.115.009475","volume":"46","author":"MR Benedictus","year":"2015","unstructured":"Benedictus MR, Van Harten AC, Leeuwis AE, Koene T, Scheltens P, Barkhof F, et al. White matter hyperintensities relate to clinical progression in subjective cognitive decline. Stroke. 2015;46:2661\u20134.","journal-title":"Stroke"},{"key":"460_CR12","doi-asserted-by":"publisher","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease\u00a0: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22. https:\/\/doi.org\/10.1186\/s40478-018-0515-3 .","DOI":"10.1186\/s40478-018-0515-3"},{"key":"460_CR13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaneurol.2014.667","volume":"71","author":"G Tosto","year":"2014","unstructured":"Tosto G, Zimmerman ME, Carmichael OT, Brickman AM. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 2014;71:872\u20137.","journal-title":"JAMA Neurol"},{"key":"460_CR14","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"key":"460_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455\u2013532.","journal-title":"Lancet Neurol"},{"key":"460_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology. 1993;43:1467.","journal-title":"Neurology"},{"key":"460_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0271678X17707397","volume":"38","author":"S Rojas","year":"2018","unstructured":"Rojas S, Brugulat-Serrat A, Bargall\u00f3 N, Minguill\u00f3n C, Tucholka A, Falcon C, et al. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-\u025b4 allele carriers aged 45\u201375: results from the ALFA study. J Cereb Blood Flow Metab. 2018;38:250\u201361.","journal-title":"J Cereb Blood Flow Metab"},{"key":"460_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jalz.2014.07.155","volume":"10","author":"AM Brickman","year":"2014","unstructured":"Brickman AM, Schupf N, Manly JJ, Stern Y, Luchsinger JA, Provenzano FA, et al. APOE \u03b54 and risk for Alzheimer\u2019s disease: do regionally distributed white matter hyperintensities play a role? Alzheimers Dement. 2014;10:619\u201329.","journal-title":"Alzheimers Dement"},{"key":"460_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1212\/WNL.0b013e31829bfda4","volume":"81","author":"S Schilling","year":"2013","unstructured":"Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, et al. APOE genotype and MRI markers of cerebrovascular disease. Neurology. 2013;81:292\u2013300.","journal-title":"Neurology"},{"key":"460_CR20","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1161\/STROKEAHA.109.555839","volume":"40","author":"O Godin","year":"2009","unstructured":"Godin O, Tzourio C, Maillard P, Alp\u00e9rovitch A, Mazoyer B, Dufouil C. Apolipoprotein E genotype is related to progression of white matter lesion load. Stroke. 2009;40:3186\u201390.","journal-title":"Stroke"},{"key":"460_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0404.2006.00779.x","volume":"115","author":"P H\u00f8gh","year":"2007","unstructured":"H\u00f8gh P, Garde E, Mortensen EL, J\u00f8rgensen OS, Krabbe K, Waldemar G. The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand. 2007;115:248\u201353.","journal-title":"Acta Neurol Scand"},{"key":"460_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-015-0111-8","volume":"7","author":"K Morgen","year":"2015","unstructured":"Morgen K, Schneider M, Frolich L, Tost H, Plichta MM, Kolsch H, et al. Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer\u2019s disease: a voxel-based lesion mapping study. Alzheimers Res Ther. 2015;7:27.","journal-title":"Alzheimers Res Ther"},{"key":"460_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2017.01.014","volume":"53","author":"CH Sudre","year":"2017","unstructured":"Sudre CH, Cardoso MJ, Frost C, Barnes J, Barkhof F, Fox N, et al. APOE \u03b54 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiol Aging. 2017;53:67\u201375.","journal-title":"Neurobiol Aging"},{"key":"460_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.STR.31.6.1263","volume":"31","author":"N Hirono","year":"2000","unstructured":"Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke. 2000;31:1263\u20138.","journal-title":"Stroke"},{"key":"460_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/ijs.12615","volume":"10","author":"DM Lyall","year":"2015","unstructured":"Lyall DM, Maniega SM, Harris SE, Bastin ME, Murray C, Lutz MW, et al. APOE\/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds. Int J Stroke. 2015;10:1297\u2013300.","journal-title":"Int J Stroke"},{"key":"460_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/jnnp.68.5.653","volume":"68","author":"H Sawada","year":"2000","unstructured":"Sawada H, Udaka F, Izumi Y, Nishinaka K, Kawakami H, Nakamura S, et al. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2000;68:653\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"460_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neurobiolaging.2013.10.072","volume":"35","author":"AC Birdsill","year":"2014","unstructured":"Birdsill AC, Koscik RL, Jonaitis EM, Johnson SC, Okonkwo OC, Hermann BP, et al. Regional white matter hyperintensities: aging, Alzheimer\u2019s disease risk, and cognitive function. Neurobiol Aging. 2014;35:769\u201376 Elsevier Ltd.","journal-title":"Neurobiol Aging"},{"key":"460_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jalz.2017.08.017","volume":"14","author":"JD Stefaniak","year":"2018","unstructured":"Stefaniak JD, Su L, Mak E, Bahaei NS, Wells K, Ritchie K, et al. Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:253\u20138.","journal-title":"Alzheimers Dement"},{"key":"460_CR29","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/hbm.22472","volume":"35","author":"V Ithapu","year":"2014","unstructured":"Ithapu V, Singh V, Lindner C, Austin BP, Hinrichs C, Carlsson CM, et al. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer\u2019s disease risk and aging studies. Hum Brain Mapp. 2014;35:4219\u201335.","journal-title":"Hum Brain Mapp"},{"key":"460_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/JAD-140924","volume":"44","author":"M Vuorinen","year":"2015","unstructured":"Vuorinen M, Spulber G, Damangir S, Niskanen E, Ngandu T, Soininen H, et al. Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging. J Alzheimers Dis. 2015;44:93\u2013101.","journal-title":"J Alzheimers Dis"},{"key":"460_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-170092","volume":"59","author":"R Stephen","year":"2017","unstructured":"Stephen R, Liu Y, Ngandu T, Rinne JO, Kemppainen N, Parkkola R, et al. Associations of CAIDE dementia risk score with MRI, PIB-PET measures, and cognition. J Alzheimers Dis. 2017;59:695\u2013705.","journal-title":"J Alzheimers Dis"},{"key":"460_CR32","doi-asserted-by":"publisher","unstructured":"Ecay-Torres M, Estanga A, Tainta M, Izagirre A, Garcia-Sebastian M, Villanua J, et al. Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults. Neurology. 2018. https:\/\/doi.org\/10.1212\/WNL.0000000000005824 .","DOI":"10.1212\/WNL.0000000000005824"},{"key":"460_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.neuroimage.2012.01.106","volume":"60","author":"E Rostrup","year":"2012","unstructured":"Rostrup E, Gouw AA, Vrenken H, Van Straaten ECW, Ropele S, Pantoni L, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors\u2014results from the LADIS study. NeuroImage. 2012;60:1597\u2013607 Elsevier Inc.","journal-title":"NeuroImage"},{"key":"460_CR34","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1212\/WNL.0000000000000505","volume":"82","author":"RP Kloppenborg","year":"2014","unstructured":"Kloppenborg RP, Nederkoorn PJ, Geerlings MI, Van Den Berg E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology. 2014;82:2127\u201338.","journal-title":"Neurology"},{"issue":"7","key":"460_CR35","doi-asserted-by":"publisher","first-page":"P925","DOI":"10.1016\/j.jalz.2018.06.1199","volume":"14","author":"A Brugulat-Serrat","year":"2018","unstructured":"Brugulat-Serrat A, Salvad\u00f3 G, Sudre CH, Grau O, Falcon C, S\u00e1nchez-Benavides G, et al. Regional distribution of white matter hyperintensity correlates with cognition in the Alfa cohort. Alzheimers Dement. 2018;14(7):P925.","journal-title":"Alzheimers Dement"},{"key":"460_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","volume":"36","author":"AM Brickman","year":"2015","unstructured":"Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer\u2019s disease incidence. Neurobiol Aging. 2015;36:27\u201332.","journal-title":"Neurobiol Aging"},{"key":"460_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","volume":"2","author":"JL Molinuevo","year":"2016","unstructured":"Molinuevo JL, Gramunt N, Gispert JD, Fauria K, Esteller M, Minguillon C, et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2016;2:82\u201392.","journal-title":"Alzheimers Dement (N Y)"},{"key":"460_CR38","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412\u20134.","journal-title":"Neurology"},{"key":"460_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1212\/WNL.52.2.231","volume":"52","author":"H Buschke","year":"1999","unstructured":"Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, et al. Screening for dementia with the Memory Impairment Screen. Neurology. 1999;52:231\u20138.","journal-title":"Neurology"},{"key":"460_CR40","first-page":"402","volume":"20","author":"P B\u00f6hm","year":"2005","unstructured":"B\u00f6hm P, Pe\u00f1a-Casanova J, Gramunt N, Manero RM, Terr\u00f3n C, Qui\u00f1ones \u00dabeda S. Spanish version of the Memory Impairment Screen (MIS): normative data and discriminant validity. Neurologia. 2005;20:402\u201311.","journal-title":"Neurologia"},{"key":"460_CR41","volume-title":"Psychology","author":"S Qui\u00f1ones-\u00dabeda","year":"2009","unstructured":"Qui\u00f1ones-\u00dabeda S. Psychology. Barcelona: Ramon Llull University; 2009."},{"key":"460_CR42","first-page":"17","volume":"123","author":"AM Ramier","year":"1970","unstructured":"Ramier AM, H\u00e9caen H. Respective r\u00f4les of frontal lesions and lesion lateralization in \u201cverbal fluency\u201d deficiencies. Rev Neurol (Paris). 1970;123:17\u201322.","journal-title":"Rev Neurol (Paris)"},{"key":"460_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/arclin\/acp042","volume":"24","author":"J Pe\u00f1a-Casanova","year":"2009","unstructured":"Pe\u00f1a-Casanova J, Qui\u00f1ones-\u00dabeda S, Gramunt-Fombuena N, Quintana-Aparicio M, Aguilar M, Badenes D, et al. Spanish multicenter normative studies (NEURONORMA project): norms for verbal fluency tests. Arch Clin Neuropsychol. 2009;24:395\u2013411.","journal-title":"Arch Clin Neuropsychol"},{"key":"460_CR44","doi-asserted-by":"crossref","unstructured":"Cacciaglia R, Molinuevo JL, Falc\u00f3n C, Brugulat-Serrat A, S\u00e1nchez-Benavides G, Gramunt N, et al. Effects of APOE -\u03b54 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer\u2019s disease. Alzheimers Dement. 2018:1\u201311.","DOI":"10.1016\/j.jalz.2018.01.016"},{"key":"460_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1097\/00005768-200008000-00011","volume":"32","author":"R Elosua","year":"2000","unstructured":"Elosua R, Garcia M, Aguilar A, Molina L, Covas MI, Marrugat J. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish women. Investigators of the MARATDON Group. Med Sci Sports Exerc. Med Sci Sports Exerc. 2000;32:1431\u20137.","journal-title":"Med Sci Sports Exerc"},{"key":"460_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerma RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"460_CR47","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1109\/TMI.2015.2419072","volume":"34","author":"CH Sudre","year":"2015","unstructured":"Sudre CH, Cardoso MJ, Bouvy WH, Biessels GJ, Barnes J, Ourselin S. Bayesian model selection for pathological neuroimaging data applied to white matter lesion segmentation. IEEE Trans Med Imaging. 2015;34:2079\u2013102.","journal-title":"IEEE Trans Med Imaging"},{"key":"460_CR48","doi-asserted-by":"publisher","first-page":"024003","DOI":"10.1117\/1.JMI.1.2.024003","volume":"1","author":"M Modat","year":"2014","unstructured":"Modat M, Cash DM, Daga P, Winston GP, Duncan JS, Ourselin S. Global image registration using a symmetric block-matching approach. J Med Imaging. 2014;1:024003.","journal-title":"J Med Imaging"},{"key":"460_CR49","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1109\/TMI.2015.2418298","volume":"34","author":"MJ Cardoso","year":"2015","unstructured":"Cardoso MJ, Modat M, Wolz R, Melbourne A, Cash D, Rueckert D, et al. Geodesic Information Flows: spatially-variant graphs and their application to segmentation and fusion. IEEE Trans Med Imaging. 2015;34:1976\u201388.","journal-title":"IEEE Trans Med Imaging"},{"key":"460_CR50","doi-asserted-by":"publisher","unstructured":"Sudre CH, Gomez Anson B, Davagnanam I, Schmitt A, Mendelson AF, Prados F, et al. Bullseye\u2019s representation of cerebral white matter hyperintensities. J Neuroradiol. 2018;45(2):114\u2013122. https:\/\/doi.org\/10.1016\/j.neurad.2017.10.001 .","DOI":"10.1016\/j.neurad.2017.10.001"},{"key":"460_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2016.03.007","volume":"42","author":"D Enache","year":"2016","unstructured":"Enache D, Solomon A, Cavallin L, K\u00e5reholt I, Kramberger MG, Aarsland D, et al. CAIDE dementia risk score and biomarkers of neurodegeneration in memory clinic patients without dementia. Neurobiol Aging. 2016;42:124\u201331 Elsevier Inc.","journal-title":"Neurobiol Aging"},{"key":"460_CR52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TLS, et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79:929\u201339.","journal-title":"Ann Neurol"},{"key":"460_CR53","doi-asserted-by":"publisher","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC, Weiner MW, et al. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934. https:\/\/doi.org\/10.1038\/ncomms11934 .","DOI":"10.1038\/ncomms11934"},{"key":"460_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","volume":"11","author":"WT Ambrosius","year":"2014","unstructured":"Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532\u201346.","journal-title":"Clin Trials"},{"issue":"7","key":"460_CR55","doi-asserted-by":"publisher","first-page":"P1665","DOI":"10.1016\/j.jalz.2018.07.004","volume":"14","author":"JD Williamson","year":"2018","unstructured":"Williamson JD. A randomized trial of intensive versus standard systolic blood pressure control and the risk of mild cognitive impairment and dementia: results from SPRINT MIND. Alzheimers Dement. 2018;14(7):P1665\u20136.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"460_CR56","doi-asserted-by":"publisher","first-page":"P627","DOI":"10.1016\/j.jalz.2018.06.2664","volume":"14","author":"MP Pase","year":"2018","unstructured":"Pase MP, Davis-Plourde K, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, et al. Impact of age on the association between vascular risk factor burden and brain volume. Alzheimers Dement. 2018;14(7):P627\u20138.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"460_CR57","doi-asserted-by":"publisher","first-page":"P626","DOI":"10.1016\/j.jalz.2018.06.2663","volume":"14","author":"CA Lane","year":"2018","unstructured":"Lane CA, Sudre CH, Barnes J, Nicholas JM, Hardy R, Parker TD, et al. Influences of blood pressure and blood pressure trajectories on cerebral pathology at age 70 \u2013 results from a British birth cohort. Alzheimers Dement. 2018;14(7):P626\u20137.","journal-title":"Alzheimers Dement"},{"key":"460_CR58","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/archneurol.2012.1527","volume":"69","author":"AM Brickman","year":"2012","unstructured":"Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, Apa Z, et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer\u2019s disease in the community. Arch Neurol. 2012;69:1621\u20137.","journal-title":"Arch Neurol"},{"key":"460_CR59","doi-asserted-by":"crossref","unstructured":"Wiegman AF, Meier IB, Provenzano FA, Schupf N, Manly JJ, Stern Y, et al. Regional white matter hyperintensity volume and cognition predict death in a multiethnic community cohort of older adults. J Am Geriatr Soc. 2013:2246\u20138.","DOI":"10.1111\/jgs.12568"},{"key":"460_CR60","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483\u201397 Elsevier Ltd.","journal-title":"Lancet Neurol"},{"key":"460_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/postgradmedj-2011-130307","volume":"88","author":"BE Grueter","year":"2012","unstructured":"Grueter BE, Schulz UG. Age-related cerebral white matter disease (Leukoaraiosis): a review. Postgrad Med J. 2012;88:79\u201387.","journal-title":"Postgrad Med J"},{"key":"460_CR62","doi-asserted-by":"publisher","unstructured":"Habes M, Sotiras A, Erus G, Toledo JB, Janowitz D, Wolk DA, et al. White matter lesions. Neurology. 2018. https:\/\/doi.org\/10.1212\/WNL.0000000000006116 .","DOI":"10.1212\/WNL.0000000000006116"},{"key":"460_CR63","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1212\/WNL.0000000000004913","volume":"90","author":"F Fatemi","year":"2018","unstructured":"Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, et al. Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly. Neurology. 2018;90:e466\u201373.","journal-title":"Neurology"},{"key":"460_CR64","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.neurobiolaging.2007.08.023","volume":"30","author":"PS Sachdev","year":"2009","unstructured":"Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging. 2009;30:946\u201356.","journal-title":"Neurobiol Aging"},{"key":"460_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","volume":"4","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M. Maternal transmission of Alzheimer\u2019s disease: prodromal metabolic phenotype and the search for genes. Hum Genomics. 2010;4:170\u201393.","journal-title":"Hum Genomics"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-018-0460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T15:48:59Z","timestamp":1606146539000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0460-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ALFA study and the MRI substudy protocols have been approved by an independent Ethics Committee Parc de Salut Mar Barcelona and registered at Clinicaltrials.gov (ALFA Identifier: NCT01835717; MRI substudy Identifier: NCT02198586). Both studies have been conducted in accordance with the directives of the Spanish Law 14\/2007, of 3 July, on Biomedical Research (Ley 14\/2007 de Investigaci\u00f3n Biom\u00e9dica).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}